Guardian Pharmacy Services, Inc. GRDN

Set alert

Price alert · GRDN

All alert types
40.00 USD -0.69 -1.70%

At close

39.99 -0.01 -0.02%

Pre-market · Nov 3, 5:34 AM ET

Bid
39.98 × 100
Ask
40.21 × 500
39.71 Day range 40.57
26.34 52-week range 48.33
YTD
+32.93%
1 year
+41.49%
Open
40.50
Prev close
40.69
Mkt cap
2.53B
Vol
410.30K
Avg vol
494.45K
EPS
1.03
P/E
38.84
Div yield
0.00%
More statistics
Low
39.71
High
40.57
Forward P/E
27.89
Beta
0.06
Short ratio
3.76
Inst. own
60.69%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
41.05
200-d avg
38.08
1y target
49.86

6M chart

Chart tools
Interval

Events in this range
  • May 6, 2026Earnings: 0.29; estimate 0.24; surprise 20.83%
  • May 7, 2026Rating: Oppenheimer · Outperform → Outperform
  • Jun 17, 2026Rating: B of A Securities · Buy → Buy
  • Jun 17, 2026Rating: Truist Securities · Buy → Buy
  • Aug 6, 2026Earnings: 0.29; estimate 0.2617; surprise 10.81%
  • Aug 7, 2026Rating: Oppenheimer · Outperform → Outperform
  • Sep 21, 2026Rating: Truist Securities · Buy → Buy
  • Sep 23, 2026Rating: Keybanc · — → Overweight
Signals (39)
NameDateAgo
MACD: Buy SignalOct 29, 20264 days ago
SMA: BearishOct 21, 20261 week ago
SMA: BearishOct 21, 20261 week ago
SMA: BullishOct 20, 20261 week ago
SMA: BullishOct 20, 20261 week ago
SMA: BearishOct 12, 20263 weeks ago
SMA: BearishOct 12, 20263 weeks ago
SMA: BullishOct 8, 20263 weeks ago
SMA: BearishOct 7, 20263 weeks ago
SMA: BullishOct 1, 20261 month ago
SMA: BearishSep 28, 20261 month ago
MACD: Sell SignalSep 24, 20261 month ago
RSI: OverboughtSep 14, 20261 month ago
RSI: OverboughtSep 10, 20261 month ago
SMA: BullishSep 3, 20262 months ago
SMA: BullishSep 3, 20262 months ago
MACD: Buy SignalSep 1, 20262 months ago
SMA: BearishAug 12, 20262 months ago
SMA: BearishAug 11, 20262 months ago
MACD: Sell SignalAug 11, 20262 months ago

Newest 20 of 39.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 49.86 +24.6% upside
Target (low)
47.00
Target (mean)
49.86
Target (high)
52.00
Ratings (0m) 7 7 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy6
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 7
  • 1 month ago 7
  • 2 months ago 6

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

GRDN analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.314290.29 – 0.330.25+25.7%365.76M-3.1%7
Next quarter0.412860.39 – 0.450.37+11.6%387.78M-2.5%7
Current year1.301.25 – 1.341.07+21.6%1.44B-0.5%7
Next year1.431.36 – 1.491.30+10.2%1.53B+6.3%7

Upgrades and downgrades

The latest rating changes

GRDN analyst upgrades and downgrades
DateFirmActionFromTo
Sep 23, 2026KeybancInitiated—Overweight
Sep 21, 2026Truist SecuritiesMaintainedBuyBuy
Aug 7, 2026OppenheimerMaintainedOutperformOutperform
Jun 17, 2026Truist SecuritiesMaintainedBuyBuy
Jun 17, 2026B of A SecuritiesMaintainedBuyBuy
May 7, 2026OppenheimerMaintainedOutperformOutperform
Apr 27, 2026B of A SecuritiesInitiated—Buy
Apr 13, 2026Truist SecuritiesMaintainedBuyBuy
Mar 30, 2026JefferiesInitiated—Buy
Mar 12, 2026OppenheimerMaintainedOutperformOutperform
Mar 12, 2026Truist SecuritiesMaintainedBuyBuy
Jan 14, 2026Stephens & Co.MaintainedOverweightOverweight
Nov 14, 2025Truist SecuritiesMaintainedBuyBuy
Oct 10, 2025OppenheimerInitiated—Outperform
Sep 26, 2025Truist SecuritiesMaintainedBuyBuy
May 19, 2025Truist SecuritiesReiteratedBuyBuy
Apr 11, 2025Truist SecuritiesMaintainedBuyBuy
Nov 15, 2024Truist SecuritiesMaintainedBuyBuy
Oct 22, 2024Stephens & Co.Initiated—Overweight
Oct 21, 2024Truist SecuritiesInitiated—Buy